Completed Access to Information Requests

Follow:

  • RSS
  • Cite

    Cite

    APA

    Open Government - Government of Canada. (2017, December 10). Completed Access to Information Requests. Retrieved from http://open.canada.ca/en/search/ati?f%5B0%5D=ss_ati_monthname_en%3AFebruary&amp%3Bamp%3Bf%5B1%5D=ss_ati_organization_en%3ACanada%20Economic%20Development%20for%20Quebec%20Regions&amp%3Bamp%3Bf%5B2%5D=ss_ati_organization_en%3ABusiness%20Development%20Bank%20of%20Canada&amp%3Bamp%3Bati%5B0%5D=ss_ati_organization_en%3ACanada%20Economic%20Development%20for%20Quebec%20Regions&amp%3Bamp%3Bati%5B1%5D=ss_ati_organization_en%3ANational%20Research%20Council%20Canada&amp%3Bati%5B0%5D=ss_ati_organization_en%3AEnvironment%20and%20Climate%20Change%20Canada&ati%5B0%5D=%3ACanada%20Border%20Services%20Agency&ati%5B1%5D=%3ACanada%20Foundation%20for%20Innovation&ati%5B2%5D=%3AMarch&ati%5B3%5D=%3ANational%20Capital%20Commission&ati%5B4%5D=ati_month_en%3AMay&ati%5B5%5D=ati_organization_en%3ADepartment%20of%20Justice%20Canada&ati%5B6%5D=ati_organization_en%3AHealth%20Canada&ati%5B7%5D=ati_organization_en%3AImmigration%20and%20Refugee%20Board%20of%20Canada&search_api_fulltext=&sort_by=year&sort_order=DESC&f%5B0%5D=ss_ati_monthname_en%3AFebruary&page=2
    MLA

    “Completed Access to Information Requests.” Open Government - Government of Canada, 10 December 2017, http://open.canada.ca/en/search/ati?f%5B0%5D=ss_ati_monthname_en%3AFebruary&amp%3Bamp%3Bf%5B1%5D=ss_ati_organization_en%3ACanada%20Economic%20Development%20for%20Quebec%20Regions&amp%3Bamp%3Bf%5B2%5D=ss_ati_organization_en%3ABusiness%20Development%20Bank%20of%20Canada&amp%3Bamp%3Bati%5B0%5D=ss_ati_organization_en%3ACanada%20Economic%20Development%20for%20Quebec%20Regions&amp%3Bamp%3Bati%5B1%5D=ss_ati_organization_en%3ANational%20Research%20Council%20Canada&amp%3Bati%5B0%5D=ss_ati_organization_en%3AEnvironment%20and%20Climate%20Change%20Canada&ati%5B0%5D=%3ACanada%20Border%20Services%20Agency&ati%5B1%5D=%3ACanada%20Foundation%20for%20Innovation&ati%5B2%5D=%3AMarch&ati%5B3%5D=%3ANational%20Capital%20Commission&ati%5B4%5D=ati_month_en%3AMay&ati%5B5%5D=ati_organization_en%3ADepartment%20of%20Justice%20Canada&ati%5B6%5D=ati_organization_en%3AHealth%20Canada&ati%5B7%5D=ati_organization_en%3AImmigration%20and%20Refugee%20Board%20of%20Canada&search_api_fulltext=&sort_by=year&sort_order=DESC&f%5B0%5D=ss_ati_monthname_en%3AFebruary&page=2
    (Report an issue with citation)
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 428 record(s)

Req # A-2022-000885

All records and communications to and from Mr. Morris Rosenberg by Health Canada from June 1st, 2021 to September 27, 2022.

Organization: Health Canada

1674 page(s)
May 2023

Req # A-2022-000890

All records regarding oral contraceptive MYA (DIN 02415380) from January 1st, 2021, to September 1st, 2022.

Organization: Health Canada

97 page(s)
May 2023

Req # A-2022-001162

Health Canada premarket review and approval of the clinical trials for the antidpressant Effexor/venlafaxine.

Organization: Health Canada

0 page(s)
May 2023

Req # A-2022-001166

All emails to and from Twitter and Facebook employees since Jan 1, 2019.

Organization: Health Canada

6 page(s)
May 2023

Req # A-2022-001376

All correspondence between Health Canada Office of Pharmaceutical Management Strategies and the Patented Medicine Prices Review Board pertaining to the October 2022 revised draft Guidelines.

Organization: Health Canada

10 page(s)
May 2023

Req # A-2022-001415

Any internal or external communications from January 1, 2018 to December 31, 2022 involving the Minister of Health or a Health Canada employee at the level of Director General, Assistant Deputy Minister, Associate Deputy Minister, or Deputy Minister, regarding the regulatory guidance document(s) used for assessment of the COVID-19 "vaccines" Comirnaty and Spikevax; defining or re-defining the term "vaccine;" the definition of a “vaccine;” and the purpose of a vaccine.

Organization: Health Canada

13 page(s)
May 2023

Req # A-2022-001494

The draft Product Monograph included in the New Drug Submission (NDS) for Captopril at the time of screening, any and all Notices of Deficiency, Notices of Non-Compliance and clarifaxes associated with Health Canada's review of the NDS.

Organization: Health Canada

97 page(s)
May 2023

Req # A-2022-001499

The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-02-24 for the medicinal ingredient aprepitant. The Screening Acceptance Letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for aprepitant which appears in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-02-24.

Organization: Health Canada

3 page(s)
May 2023

Req # A-2022-001505

A list of all drug manufacturing plants currently banned from producing drugs for the Canadian market. Please include the reason for the ban, the location of the plant and the name of the company running the plant.

Organization: Health Canada

7589 page(s)
May 2023

Req # A-2022-001509

The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-02-24 for the medicinal ingredients methotrexate & methotrexate sodium. The Screening Acceptance Letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for methotrexate & methotrexate sodium which appears in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-02-24.

Organization: Health Canada

5 page(s)
May 2023
Date modified: